FDA Announces Grant Funds for Georgetown University Study on Endocrine Disruptors and Breast Cancer

Summary

The FDA is providing grant funds to Georgetown University to investigate the link between early exposure to endocrine disruptors and increased breast cancer risk, with a focus on epigenetic changes in transcription factors.